MedDataX Logo

Assessing the Magnitude of Anisometropia in Patients Wearing Misight 1 Day Contact Lens

NCT ID: NCT06744478

Last Updated: 2024-12-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-01-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The effectiveness of Misight 1 Day Contact Lens in retarding anisometropic progression has not been investigated before. This study is aimed to elucidate the efficacy of Misight 1 Day Contact Lens for anisometropia control.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia Anisometropia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

myopic children

Myopic children use Misight 1 Day Contact Lens every day for myopia and anisometropia control.

Misight 1 Day Contact Lens

Intervention Type DEVICE

Misight 1 Day Contact Lens wearing for myopia control

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Misight 1 Day Contact Lens

Misight 1 Day Contact Lens wearing for myopia control

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 8-23 years old children diagnosed with anisometropia and are willing to accept MiSight® 1 Day contact lens wearing treatment.
* No congenital eye diseases or eye diseases such as strabismus and amblyopia.
* Those who have been stated to be willing to participate in the program for at least 24 months and accept various evaluations.

Exclusion Criteria

* Ocular surface disease( dry eye, keratoconus..)
* Allergy to contact lens
* Received eye surgery before
* The cornea is infected (bacterial, fungal or viral infection).
* Strabismus
* Premature birth
Minimum Eligible Age

8 Years

Maximum Eligible Age

23 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Buddhist Tzu Chi General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Shang-Yen WU

Hualien City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB113-170-A

Identifier Type: -

Identifier Source: org_study_id